Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

United Therapeutic (UTHR)

118.04 0.49 (0.42%)

02-23 16:00

Open:

118.82

Pre. Close:

117.55

High:

119.2

Low:

115.71

Volume:

382,825

Market Cap:

5104M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

119.37 - 120.039

120.039 - 120.651

Low:

113.948 - 114.821

114.821 - 115.621

Close:

116.769 - 118.041

118.041 - 119.205

Technical analysis  (as of: 2018-02-23 4:42:43 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 155.11     One year: 167.88

Support:

Support1: 115.12    Support2: 95.78

Resistance:

Resistance1: 132.80    Resistance2: 143.73

Pivot:

129.21

Moving Averages:

MA(5): 125.53     MA(20): 130.75

MA(100): 130.74     MA(250): 129.68

MACD:

MACD(12,26): -3.90     Signal(12,26,9): -2.63

%K %D:

%K(14,3): 9.94     %D(3): 30.64

RSI:

RSI(14): 33.61

52-Week:

High: 153.58  Low: 112.01  Change(%): -22.6

Average Vol(K):

3-Month: 44372  10-Days 58621

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
UTHR has closed above bottom band by 2.9%. Bollinger Bands are 68.8% wider than normal. The large width of the bands suggest high volatility as compared to UTHR's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Wed, 21 Feb 2018 18:22:30 GMT
United Therapeutics' (UTHR) CEO Martine Rothblatt on Q4 2017 Results ...

Thu, 22 Feb 2018 12:33:45 GMT
United Therapeutics (UTHR) Q4 Earnings Decline on High Costs

Fri, 16 Feb 2018 20:15:00 GMT
United Therapeutics reaches patent settlement with Actavis

Fri, 16 Feb 2018 00:56:15 GMT
United Therapeutics Announces Settlement Of Patent Litigation With Actavis ...

Wed, 14 Feb 2018 10:52:30 GMT
United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

43.21

Shares Float (M)

43.16

% Held by Insiders

% Held by Institutions

95.80

Shares Short (K)

4652

Shares Short Prior Month (K)

5880

Stock Financials

EPS

11.550

EPS Est. Current Year

10.600

EPS Est. Next Year

10.970

EPS Est. Next Quarter

2.850

Forward EPS

11.713

Book Value (p.s.)

2.820

PEG Ratio

-0.64

Profit Margin

31.64

Operating Margin

63.49

Return on Assets (ttm)

19.2

Return on Equity (ttm)

25.5

Qtrly Rev. Growth

9.1

Gross Profit (p.s.)

36.761

Sales Per Share

EBITDA (p.s.)

19.412

Qtrly Earnings Growth

70.80

Operating Cash Flow (M)

723.40

Levered Free Cash Flow (M)

825.65

atoplab.com

Valuation

P/E

10.22

P/E Growth Ratio

P/BV

41.86

P/S

133801376.00

P/CF

7.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.